PLEURAL MESOTHELIOMA
Clinical trials for PLEURAL MESOTHELIOMA explained in plain language.
Never miss a new study
Get alerted when new PLEURAL MESOTHELIOMA trials appear
Sign up with your email to follow new studies for PLEURAL MESOTHELIOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Can a new nucleotide analogue boost cancer treatment?
Disease control TerminatedThis trial is testing an experimental drug called NUC-3373, a nucleotide analogue, in combination with standard cancer drugs for people with advanced solid tumors. The study has two parts: one combining NUC-3373 with pembrolizumab, and the other combining it with docetaxel. The g…
Matched conditions: PLEURAL MESOTHELIOMA
Phase: PHASE1, PHASE2 • Sponsor: NuCana plc • Aim: Disease control
Last updated Jul 25, 2026 00:00 UTC
-
Experimental lung cancer combo trial ends early
Disease control TerminatedThis phase 2 trial tested a new drug called THOR-707 (Pegenzileukin) combined with other cancer treatments, including pembrolizumab, in 106 people with advanced lung cancer or pleural mesothelioma. The goal was to see if the combination could shrink tumors. However, the study was…
Matched conditions: PLEURAL MESOTHELIOMA
Phase: PHASE2 • Sponsor: Sanofi • Aim: Disease control
Last updated Jun 27, 2026 07:53 UTC
-
A simple breath test could spot mesothelioma years earlier
Diagnosis TerminatedThis study explores whether chemicals in a person's breath, called volatile organic compounds, can serve as early warning signs of pleural mesothelioma in people who have been exposed to asbestos. Researchers will also check if a blood marker, SMRP, adds to the breath test's accu…
Matched conditions: PLEURAL MESOTHELIOMA
Sponsor: Henry Ford Health System • Aim: Diagnosis
Last updated Aug 12, 2026 00:00 UTC